Process for the Preparation of Novel Amorphous Montelukast Sodium
A process for the preparation of novel amorphous montelukast sodium by dissolving montelukast free acid in an organic solvent, converting into its alkali salt followed by vacuum drying or spray drying the solution. Alternatively by dissolution of montelukast sodium in organic solvent followed by vacuum drying or spray drying the solution.
1 . A process for the preparation of amorphous montelukast sodium comprising
dissolving montelukast free acid in an organic solvent or a mixture of organic solvents,
treating with molar equivalents of sodium hydroxide solution,
removing insolubles (if any),
drying the solution by vacuum drying or spray drying,
which is characterized by the typical X-ray diffractions as shown in FIG. 1 .
2 . A process as claimed in claim 1 , wherein the montelukast free acid is either in solid form or in solution form obtained from montelukast base salts.
3 . A process as claimed in claim 1 , wherein the organic solvent(s) is methanol, ethanol, isopropanol, toluene, aectonitrile, ethyl acetate, isopropyl acetate, acetone or a mixture thereof.
4 . A process for the preparation of amorphous montelukast sodium comprising
dissolving montelukast sodium in an organic solvent or a mixture of organic solvents,
removing the insolubles (if any),
removing the solvent either by vacuum drying or by spray drying,
which is characterized by the typical X-ray diffractions as shown in FIG. 1 .
5 . A process as claimed in claim 1 , wherein the organic solvent(s) is methanol, ethanol, isopropanol, toluene, aectonitrile, ethyl acetate, isopropyl acetate, acetone or a mixture thereof.
6 . A process as claimed in claim 4 , wherein the utilized montelukast sodium is in a known amorphous or crystalline forms.
7 . Novel amorphous montelukast sodium characterized by the XRD pattern as shown in FIG. 1 .